In pristane-induced lupus mouse model, TLR2−/− mice show lower ANA levels and reduced lupus pathogenesis, together with a reduced level of HMGB1, a well-known endogenous TLR ligand [73]. The gene discussed is HMGB1; the disease is systemic lupus erythematosus.